Contemporary trends in use of mechanical circulatory support in patients with acute MI and cardiogenic shock.

The trial did, however, report an absolute risk reduction of 28% in 30-day mortality when MCS was applied pre-PCI, although the numbers were small and difference did not reach statistical significance. 10 A recent single-centre observational study found a non-significant absolute 15% lower 30-day mortality among 62 patients receiving an Impella compared with 54 patients receiving an IABP, despite the fact that patients receiving Impella had more often received out-of-hospital cardiopulmonary res

also in 111,027 other papers